CN Patent

CN114828873A — 含有达托霉素的稳定的冷冻干燥制剂

Assigned to Nipro Corp · Expires 2022-07-29 · 4y expired

What this patent protects

本发明的目的在于提供能够稳定化至能够在室温下保存的程度的含有达托霉素的冷冻干燥制剂。一种稳定的冷冻干燥制剂，其含有达托霉素以及选自L‑精氨酸、肌醇、右旋糖酐、葡甲胺、聚乙二醇和L‑组氨酸中的一种或两种以上稳定剂。

USPTO Abstract

本发明的目的在于提供能够稳定化至能够在室温下保存的程度的含有达托霉素的冷冻干燥制剂。一种稳定的冷冻干燥制剂，其含有达托霉素以及选自L‑精氨酸、肌醇、右旋糖酐、葡甲胺、聚乙二醇和L‑组氨酸中的一种或两种以上稳定剂。

Drugs covered by this patent

Cytoxan (Lyophilized) (cyclophosphamide) · Baxter

Patent Metadata

Patent number: CN114828873A
Jurisdiction: CN
Classification: —
Expires: 2022-07-29
Drug substance claim: No
Drug product claim: No
Assignee: Nipro Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.